Krystal Biotech, Inc.
USD354.86
+13.07 (+3.82%)
CEO
Krish S. Krishnan
IPO Date
2017-09-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$337.24
Prev. Close
$341.79
Day Low
$335.00
Day High
$355.85
52W Low
$130.50
52W High
$382.54
Market Cap
$10.46B
Volume
0.68M
| 1,000 |
| $347.27 |
| 26 Jun 2026 | Thomas John Charles | EVP, General Counsel | M-Exempt | Disposed | 1,000 | $179.25 |
| 5 Jun 2026 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | S-Sale | Disposed | 320 | $300.75 |
| 5 Jun 2026 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | S-Sale | Disposed | 593 | $302.25 |
| 5 Jun 2026 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | S-Sale | Disposed | 247 | $303.17 |
| 5 Jun 2026 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | S-Sale | Disposed | 400 | $304.89 |
| 5 Jun 2026 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | S-Sale | Disposed | 480 | $305.87 |
| 5 Jun 2026 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | S-Sale | Disposed | 1,348 | $307.09 |
| 5 Jun 2026 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | S-Sale | Disposed | 12,729 | $307.81 |